News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
707,005 Results
Type
Article (41908)
Company Profile (332)
Press Release (664765)
Section
Business (210186)
Career Advice (2079)
Deals (36581)
Drug Delivery (100)
Drug Development (82851)
Employer Resources (171)
FDA (16487)
Job Trends (15358)
News (355508)
Policy (33835)
Tag
Academia (2575)
Alliances (51175)
Alzheimer's disease (1270)
Approvals (16422)
Artificial intelligence (156)
Bankruptcy (362)
Best Places to Work (11703)
Biotechnology (216)
Breast cancer (189)
Cancer (1349)
Cardiovascular disease (111)
Career advice (1740)
Cell therapy (273)
Clinical research (66129)
Collaboration (455)
Compensation (248)
COVID-19 (2611)
C-suite (108)
Data (1369)
Diabetes (165)
Diagnostics (6257)
Earnings (86562)
Employer resources (149)
Events (112804)
Executive appointments (372)
FDA (17128)
Funding (414)
Gene therapy (203)
GLP-1 (624)
Government (4451)
Healthcare (18870)
Infectious disease (2700)
Inflammatory bowel disease (116)
Interviews (320)
IPO (16605)
Job creations (4052)
Job search strategy (1489)
Layoffs (437)
Legal (8324)
Lung cancer (189)
Manufacturing (203)
Medical device (13293)
Medtech (13298)
Mergers & acquisitions (20099)
Metabolic disorders (449)
Neuroscience (1592)
NextGen Class of 2024 (6625)
Non-profit (4516)
Northern California (1646)
Obesity (260)
Opinion (206)
Patents (117)
People (58364)
Pharmaceutical (98)
Phase I (20478)
Phase II (29094)
Phase III (21829)
Pipeline (505)
Postmarket research (2650)
Preclinical (8729)
Radiopharmaceuticals (241)
Rare diseases (263)
Real estate (6242)
Regulatory (22472)
Research institute (2358)
Resumes & cover letters (358)
Southern California (1429)
Startups (3712)
United States (14920)
Vaccines (579)
Weight loss (190)
Date
Today (3)
Last 7 days (684)
Last 30 days (2373)
Last 365 days (35781)
2024 (34972)
2023 (40634)
2022 (51803)
2021 (56338)
2020 (54810)
2019 (47414)
2018 (35783)
2017 (33148)
2016 (32669)
2015 (38619)
2014 (32519)
2013 (27637)
2012 (29733)
2011 (30494)
2010 (28504)
Location
Africa (776)
Arizona (201)
Asia (40118)
Australia (6433)
California (3707)
Canada (1415)
China (297)
Colorado (170)
Connecticut (173)
Europe (85406)
Florida (515)
Georgia (130)
Illinois (381)
Indiana (226)
Maryland (621)
Massachusetts (2926)
Michigan (171)
Minnesota (287)
New Jersey (1079)
New York (1052)
North Carolina (750)
Northern California (1646)
Ohio (144)
Pennsylvania (907)
South America (1157)
Southern California (1429)
Texas (540)
Utah (106)
Washington State (398)
707,005 Results for "plex pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
PolyPid Announces Research and Development Collaboration with ImmunoGenesis Leveraging PLEX Technology to Enhance Cancer Immunotherapy
December 12, 2024
·
4 min read
Drug Development
PolyPid to Host Virtual KOL Event on June 17, 2024, and Provide an Update on the Company’s Ongoing D-PLEX₁₀₀ Phase 3 Trial
PolyPid Ltd. announced that it will host a virtual Key Opinion Leader event on Monday, June 17, 2024, at 10:00 AM ET, to discuss the significant unmet medical need in surgical site infections and provide an update on the Company’s ongoing D-PLEX100 Phase 3 trial.
June 10, 2024
·
5 min read
Drug Development
PolyPid Announces Enrollment of 200th Patient in Ongoing SHIELD II Phase 3 Trial Evaluating D-PLEX₁₀₀ for the Prevention of Abdominal Colorectal Surgical Site Infections
PolyPid Ltd., a late-stage biopharma company aiming to improve surgical outcomes, announced that it has enrolled the 200th patient in its ongoing SHIELD II Phase 3 trial for D-PLEX100 for the prevention of surgical site infections in patients undergoing abdominal colorectal surgery with large incisions.
April 30, 2024
·
6 min read
Press Releases
PolyPid Announces Publication in International Journal of Surgery Highlighting Results of Phase 3 SHIELD I Trial of D-PLEX₁₀₀ in Prevention of Surgical Site Infections in Abdominal Colorectal Surgery
October 21, 2024
·
9 min read
Biotech Bay
10x Genomics Launches 5,000-Plex Gene Panel for Xenium
10x Genomics, Inc., a leader in single cell and spatial biology, announced the launch of its Xenium Prime 5K Pan-Tissue and Pathways panel.
May 29, 2024
·
5 min read
Drug Development
PolyPid Announces Publication of Preclinical Data Further Supporting the Good Safety Profile of D-PLEX₁₀₀ and PLEX Technology Platform
PolyPid Ltd. today announced the publication of positive preclinical results demonstrating, for the first time, the safety profile of D-PLEX.
October 4, 2023
·
4 min read
Press Releases
PolyPid Announces Last Patient In for Planned Unblinded Interim Analysis in the Ongoing SHIELD II Phase 3 Trial Evaluating D-PLEX₁₀₀ for the Prevention of Abdominal Colorectal Surgical Site Infections
October 1, 2024
·
6 min read
BioMidwest
SomaLogic and Korea’s DNA Link partner to bring the 7,000-plex SomaScan® platform to the fast-growing Asia-Pacific proteomics market
SomaLogic Inc., a leader in data-driven proteomics technology, announced its partnership with DNA Link, an innovator in personalized and precision medicine, to offer the 7,000-plex SomaScan® platform to their customers.
September 19, 2023
·
4 min read
PolyPid Announces Successful Completion of Manufacturing Process Validation for D-PLEX₁₀₀
PolyPid Ltd., a late-stage biopharma company aiming to improve surgical outcomes, announced the successful completion of the production of three process validation batches of D-PLEX100 which have started stability program.
September 19, 2023
·
5 min read
Genetown
Akoya Biosciences Announces Peer-Reviewed Publication Using Ultrahigh-Plex Spatial Phenotyping of Head and Neck Cancer to Identify Distinct Immune and Metabolic Signatures
Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that researchers from Akoya Biosciences and The University of Queensland’s Frazer Institute have comprehensively mapped the spatial proteome of head and neck squamous cell carcinoma (HNSCC) using ultrahigh-plex spatial phenotyping.
October 17, 2023
·
4 min read
1 of 70,701
Next
